Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy
-
Narrated by:
-
By:
About this listen
Interview with Michael A. Postow, MD, author of Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy. Hosted by Vivek Subbiah, MD.
Related Content:
- Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
No reviews yet